These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 36982356

  • 1. Genetics of Multiple System Atrophy and Progressive Supranuclear Palsy: A Systemized Review of the Literature.
    Bougea A.
    Int J Mol Sci; 2023 Mar 09; 24(6):. PubMed ID: 36982356
    [Abstract] [Full Text] [Related]

  • 2. Genetics of Progressive Supranuclear Palsy: A Review.
    Wen Y, Zhou Y, Jiao B, Shen L.
    J Parkinsons Dis; 2021 Mar 09; 11(1):93-105. PubMed ID: 33104043
    [Abstract] [Full Text] [Related]

  • 3. DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation.
    Murthy M, Fodder K, Miki Y, Rambarack N, De Pablo Fernandez E, Pihlstrøm L, Mill J, Warner TT, Lashley T, Bettencourt C.
    Acta Neuropathol; 2024 Jul 12; 148(1):4. PubMed ID: 38995454
    [Abstract] [Full Text] [Related]

  • 4. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
    Carlos AF, Sekiya H, Koga S, Pham NTT, Ali F, Botha H, Clark HM, Coon EA, Lowe V, Ahlskog JE, Trejo-Lopez JA, Dickson DW, Whitwell JL, Josephs KA.
    Parkinsonism Relat Disord; 2022 Aug 12; 101():9-14. PubMed ID: 35752126
    [Abstract] [Full Text] [Related]

  • 5. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
    Han YH, Lee JH, Kang BM, Mun CW, Baik SK, Shin YI, Park KH.
    J Neurol Sci; 2013 Feb 15; 325(1-2):29-35. PubMed ID: 23260321
    [Abstract] [Full Text] [Related]

  • 6. Clinical correlates of fear of falling in progressive supranuclear palsy and multiple system atrophy.
    Martínez-Villota VA, Terroba-Chambi C, Castillo-Torres SA, Rossi M, Merello M.
    Eur J Neurol; 2023 Aug 15; 30(8):2261-2266. PubMed ID: 37183570
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
    Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC.
    Brain; 2006 Apr 15; 129(Pt 4):1040-9. PubMed ID: 16455792
    [Abstract] [Full Text] [Related]

  • 8. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M, Tada M, Onodera O, Takahashi H, Nishizawa M, Shimohata T.
    Parkinsonism Relat Disord; 2013 Dec 15; 19(12):1149-51. PubMed ID: 23916652
    [Abstract] [Full Text] [Related]

  • 9. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.
    Lee JH, Han YH, Kang BM, Mun CW, Lee SJ, Baik SK.
    J Neurol; 2013 Aug 15; 260(8):2094-101. PubMed ID: 23670309
    [Abstract] [Full Text] [Related]

  • 10. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.
    Nicoletti G, Rizzo G, Barbagallo G, Tonon C, Condino F, Manners D, Messina D, Testa C, Arabia G, Gambardella A, Lodi R, Quattrone A.
    Radiology; 2013 Jun 15; 267(3):843-50. PubMed ID: 23329659
    [Abstract] [Full Text] [Related]

  • 11. DCTN1 mutation analysis in Italian patients with PSP, MSA, and DLB.
    Procopio R, Gagliardi M, D'Amelio M, Brighina L, Nicoletti G, Morelli M, Bonapace G, Quattrone A, Annesi G.
    Neurobiol Aging; 2020 Sep 15; 93():143.e5-143.e7. PubMed ID: 32402491
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Coexistence of PSP and MSA: a case report and review of the literature.
    Uchikado H, DelleDonne A, Uitti R, Dickson DW.
    Acta Neuropathol; 2006 Feb 15; 111(2):186-92. PubMed ID: 16456665
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic advances in multiple system atrophy and progressive supranuclear palsy.
    Poewe W, Mahlknecht P, Krismer F.
    Mov Disord; 2015 Sep 15; 30(11):1528-38. PubMed ID: 26227071
    [Abstract] [Full Text] [Related]

  • 16. Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.
    Street D, Jabbari E, Costantini A, Jones PS, Holland N, Rittman T, Jensen MT, Chelban V, Goh YY, Guo T, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Houlden H, Morris H, Rowe JB.
    Brain; 2023 Aug 01; 146(8):3232-3242. PubMed ID: 36975168
    [Abstract] [Full Text] [Related]

  • 17. Genetics of Progressive Supranuclear Palsy.
    Im SY, Kim YE, Kim YJ.
    J Mov Disord; 2015 Sep 01; 8(3):122-9. PubMed ID: 26413239
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA as Candidate Biomarkers in Atypical Parkinsonian Syndromes: Systematic Literature Review.
    Bougea A.
    Medicina (Kaunas); 2022 Mar 26; 58(4):. PubMed ID: 35454322
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease.
    Tan EK, Skipper L, Chua E, Wong MC, Pavanni R, Bonnard C, Kolatkar P, Liu JJ.
    Mov Disord; 2006 Jul 26; 21(7):997-1001. PubMed ID: 16602113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.